De-escalation approaches in the treatment of women with HER2-positive breast cancer need to be personalized, according to Carmen Criscitiello at the European Institute of Oncology. Her comments will be included in a presentation of updated research results at the inaugural ESMO Breast Cancer Congress 2019, May 2-4, in Berlin.
A new study suggests Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million—about 2% of the overall costs in the first year. The study, conducted by Georgetown Lombardi Comprehensive Cancer Center and NCI researchers, was published in JNCI.
Average-risk women, between the ages of 50 and 74, who have no symptoms for breast cancer should undergo breast cancer screening with mammography every other year, the American College of Physicians states in a new evidence-based guidance statement published today in Annals of Internal Medicine.
UCLA researchers have developed a new artificial intelligence system to help radiologists improve their ability to diagnose prostate cancer. The system, called FocalNet, helps identify and predict the aggressiveness of the disease evaluating magnetic resonance imaging, or MRI, scans, and it does so with nearly the same level of accuracy as experienced radiologists.
Mount Sinai Health System has launched a clinical trial of a new imaging device for detecting head and neck cancer during surgery.
A new study reports that a type of cervical cancer that is less amenable to Pap testing is increasing in several subpopulations of women, pointing to the growing importance of human papillomavirus testing and vaccination. The study can be found here.
The American Society of Clinical Oncology, the American Society of Hematology, and the National Comprehensive Cancer Network said they have received a key clarification from the Centers for Disease Control and Prevention on prescribing opioids to manage pain from certain conditions.
Medtronic announced results of a study published in JAMA Network Open that demonstrates a reduction in health care utilization and cost for cancer pain patients using targeted drug delivery and conventional medical management vs. CMM alone.
The American Society of Clinical Oncology announced formation of a task force aimed at reducing disparities and improving outcomes for patients and survivors of cancer who live in rural communities. The new “Rural Cancer Care Task Force” will identify opportunities to close the rural cancer care gap and implement strategies to improve rural cancer care in the United States.
People with glioblastoma are being deprived of the best chance of survival: easy access to clinical trials and off-label treatments, according to a survey of 162 patients and caregivers conducted by OurBrainBank.
